Profectus BioSciences' Grant - II Round

Profectus BioSciences raised a round of funding on October 23, 2014. Investors include U.S. Department of Health and Human Services.

Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…

Articles about Profectus BioSciences' Grant - II Round: